Oral squamous cell carcinoma that is one of the most common malignancies in head and neck can be treated by chemotherapy, surgical operation, radiotherapy or combinations of the treatments. The patients usually have poor prognosis and survival rate in 5 years is about 50% (
1,
2). The most important risk factors for OSCC are drinking alcohol, use of tobacco, diet low in fruits and vegetables and infection with high-risk human papilloma virus (HPV) (
3). OSCC is most frequently diagnosed late in the course of the disease because patients do not understand the significance of early signs and symptoms (
4). In Western countries, OSCC affects the floor of the mouth in 15% - 20% of the cases and the tongue in 20% - 40% of cases and together these sites account for about 50% of all cases of OSCC (
5). Introducing the early diagnosis biomarkers of oral cancer is essential in obtaining a better prognosis and quality of life of affected patients (
6). Several researchers have investigated the molecular aspects of OSCC such as genomics and proteomics studies (
7,
8). HMGB1 polymorphism 1177G/C (
7), CTLA-4 gene polymorphism (
9) and CYP1A1 exon 7 containing G allele (
10) were at increased risk for OSCC. Tropomyosin 2, myosin light chain 1, alpha B- crystallin, heat shock protein 27, stratifin and flavin reductase have significantly been reported over-expressed in OSCC (
11). Melanoma is a malignant tumor of cutaneous melanocytes. Incidence of melanoma is usually lower than other skin cancers such as basal cell cancer and squamous cell cancer. However, melanoma is more invasive and has a higher lethality than other skin cancers such as Squamous cell carcinoma skin (
12). Squamous cell carcinoma (SCC or SqCC), also known as squamous cell cancer, is cancer that begins from squamous cells, a type of skin cell. Cancers that involve head and neck such as oral cancer, are most often squamous cell cancers (
13). Despite the various previous studies in this filed, yet special prognostic biomarkers are to be introduced, which could be used in diagnostics and, consequently, in the selection of the most effective treatment (
14). A main challenge of cancer study is to organize the selection of cancer drug targets (
15) but with advances in PPI discovery targeting agents. In clinical settings the importance of PPI study as an anticancer strategy has become a reality concept (
16). Recently PPI network analysis of many diseases and disorders has attracted growing attention of scientist in medicine (
17-
19). Molecular biology plays a principal role in validation of target identification, concepts and pathway studies. Network science not only can elevate our view of cell biology (
20) but also it is one of the mechanisms that can clear the aspects of pathogenesis (
21-
26). We want to reveal 11-dehydrosinulariolide effect on oral cancer with squamous cell carcinoma origin and melanoma cancer with different origin of Squamous cell carcinoma. It can provide the opportunity to investigate the similarities and differences of response to same treatment in cancers with different origins. In this study, a PPI network analysis was performed to investigate the effects of 11-dehydrosinulariolideon (anti-cancer drug) on oral cancer cells (Ca9-22 and CAL-27) and melanoma cells (A2058 Cell line). Overall, these results can provide clues for the investigation of the molecular mechanisms of the anti-tumor effects of 11-dehydrosinulariolide on the mentioned cancer cells and could provide valuable information for drug development and OSCC treatment timely.